Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $57.0 million.

  • Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) rose 1.23% to $57.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.5 million, marking a year-over-year increase of 1.23%. This contributed to the annual value of $57.0 million for FY2024, which is 0.46% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Shares Outstanding (Weighted Average) of $57.0 million as of FY2024, which was up 0.46% from $56.8 million recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) registered a high of $59.3 million during FY2022, and its lowest value of $56.8 million during FY2023.
  • In the last 3 years, Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) had a median value of $57.0 million in 2024 and averaged $57.7 million.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) fell by 9.67% in 2020 and then increased by 2.78% in 2021.
  • Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) (Yearly) stood at $56.9 million in 2020, then climbed by 2.78% to $58.5 million in 2021, then grew by 1.45% to $59.3 million in 2022, then decreased by 4.30% to $56.8 million in 2023, then increased by 0.46% to $57.0 million in 2024.